A randomized phase III trial of anthracyclines followed by taxane versus taxane plus carboplatin as (neo)adjuvant therapy in patients with triple-negative breast cancer: KCSG BR 15-1 PEARLY trial

Annals of Oncology · Elsevier

Аннотация

Publication date: October 2026 Source: Annals of Oncology, Volume 37, Issue 10 Author(s): G.M. Kim, K.H. Jung, H.C. Jeung, J. Lee, K.S. Lee, S.A. Im, S.Y. Kang, S.H. Kim, H.J. Kim, K.H. Park, Y.S. Chae, S.J. Koh, E.K. Cho, K.U. Park, S.S. Lee, J.Y. Kim, I.S. Choi, S.K. Baek, Y.W. Moon, S.G. Kim

Читать у издателя →

Похожие статьи